Literature DB >> 23964335

Concordance of endoscopic ultrasonography-guided fine needle aspiration diagnosis with the final diagnosis in subepithelial lesions.

Erkan Cağlar1, Ibrahim Hatemi, Deniz Atasoy, Gürhan Sişman, Hakan Sentürk.   

Abstract

BACKGROUND/AIMS: In this study we aimed to determine the rate of concordance of endoscopic ultrasonography (EUS)-guided fine needle aspiration (FNA) diagnosis with the final diagnosis obtained by surgery or endoscopic resection and follow-up in upper gastrointestinal subepithelial lesions.
METHODS: We retrospectively studied patients with subepithelial lesions who underwent EUS at our center from 2007 to 2011.
RESULTS: We had a final diagnosis in 67 patients (mean age±SD, 51.23±12.48 years; 23 [34.3%] female, 44 [65.6%] male). EUS-FNA was performed in all of the patients. On-site pathology was not performed. In nine of the patients, the obtained material which was obtained was insufficient. The cytologic examination was benign in 31 and malignant in 27 of the patients. Based on the final diagnosis, the EUS-FNA had a sensitivity of 96%, a specificity of 100%, and a diagnostic yield of 85%.
CONCLUSIONS: The diagnostic yield of EUS-FNA, in the absence of the on-site cytopathologist, is feasible for the diagnosis of subepithelial lesions of the upper gastrointestinal system.

Entities:  

Keywords:  Biopsy, fine-needle; Endosonography; Subepithelial lesion

Year:  2013        PMID: 23964335      PMCID: PMC3746143          DOI: 10.5946/ce.2013.46.4.379

Source DB:  PubMed          Journal:  Clin Endosc        ISSN: 2234-2400


INTRODUCTION

Subepithelial lesions represent a spectrum of lesions located beneath the mucosal lining of the gastrointestinal (GI) tract. They are relatively common at routine upper GI endoscopy with an incidence of 0.3%.1 Endoscopic ultrasonography (EUS) can differentiate an intramural lesion from an extramural one. It can identify the GI wall layer from which the lesion originates and can detect if the lesion is cystic or solid.2 EUS and fine needle aspiration (FNA) cytology is useful in the evaluation of subepithelial lesions of the upper GI tract.3 In this study we evaluated the consistency of the EUS-FNA diagnosis with our final diagnosis reached by surgery, endoscopic resection or endoscopic follow-up. As a secondary aim, we investigated the factors which could be important to result in insufficiency of the material obtained by EUS-FNA.

MATERIALS AND METHODS

In this retrospective study, we evaluated the EUS examinations performed for upper GI subepithelial lesions from 2007 to 2011 at our endoscopy department. All patients underwent a standard upper endoscopy before EUS examination. EUS examinations were performed with curvilinear-echoendoscope (Pentax FG-34 UA; Pentax, Tokyo, Japan) in left lateral decubitus position. All EUS-FNAs were performed with a 22-gauge Echotip needle (Wilson Cook, Winston-Salem, NC, USA). Doppler ultrasound was employed to ensure the absence of intervening vessels before FNA procedure. All EUS examinations were performed by an experienced endosonographer. Lesions were defined as intramural or extramural as well as solid or cystic. Size, shape and delineation, and echo pattern were noted. In this study lesions resulted from compression of other normal organs were excluded. Cytology specimens were prepared for direct smears or thin prep with routine Papanicolaou staining. There was no on-site cytopathologist. Cytologic results from EUS-FNA were categorized as benign, malignant, or inadequate. Inadequate specimen was defined as a sample from which the cytopathologist could not make a diagnosis by examining the direct smears or the cell block in case it was obtained. The diagnosis of gastrointestinal stromal tumor (GIST) was made according to mitotic figure and cellular atypia of the spindle-type cells and the c-kit staining obtained from the cell blocks of the patients. Patients with submucosal tumors who had clinical and/or morphologic criteria consistent with overt or potential malignancy underwent surgery. The final diagnosis was established according to the endoscopic and surgical resection, or according to the clinical follow-up findings. We determined the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of EUS-FNA to differentiate a malignant subepithelial lesion from a benign subepithelial lesion. Mean values were calculated unless otherwise indicated. Intragroup comparison of operating characteristics was done using the chi-square test. The factors which can be important in failing to obtain a sufficient FNA material were investigated by univariate and multivariate analyses. The statistical analysis was conducted using SPSS software version 13.0 (SPSS Inc., Chicago, IL, USA). Statistical significance was set at p<0.05.

RESULTS

During the period of the study, 87 patients were referred to our center due to subepithelial lesions. Of that 15 were identified as epithelial lesions. Eight of these lesions were esophageal cancer and seven were gastric cancer. In five of the cases, final diagnosis was established by EUS and visual findings. These cases were diagnosed as lipoma, based on the pillow sign and with the EUS findings (four of these lesions were in the stomach and one was at the duodenum). EUS-FNA was performed in 67 patients (mean age±SD, 51.23±12.48 years; range, 25 to 72; 23 [34.3%] female, 44 [65.6%] male). The mean number of FNA passes was four (range, 3 to 5). There were no procedure-related complications. The mean size of the FNA performed subepithelial lesions was 30.8±12.28 mm (range, 5 to 70). The location, size, EUS layer of origin and echo pattern of the lesions are summarized in Table 1. In nine of 67 patients (13.4%) who underwent FNA, the biopsy material was insufficient for histopathological examination. We did not repeat FNA in these subjects. Surgery was performed in one (final diagnosis was GIST) and mediastinoscopy was performed in another of them (final diagnosis was Langerhans cell histiocytosis). The final diagnosis was obtained by endoscopic follow-up in five patients (these lesions were considered as leiomyoma). In two of the cases, endoscopic submucosal dissection was performed to the lesions, which were diagnosed as ectopic pancreatic tissue.
Table 1

Imaging Features of 67 Subepithelial Lesions

Of 58 patients, in whom EUS-FNA was diagnostic, surgery was performed in 26 cases and the final diagnosis was GIST. In five cases the final diagnosis was obtained by endoscopic resection (ectopic pancreas in two, granular cell tumor in one, fibroma in one, and hyperplastic polip in one of the cases). In 27 patients, the final diagnosis was assumed by endoscopic follow-up: leiomyoma in 21 and cyst of duplication in four patients. In two patients the diagnoses of lung cancer and melanoma metastasis were made by other radiological or clinical findings (Fig. 1).
Fig. 1

Flow chart showing diagnostic methods used in the study. FNA, fine needle aspiration.

The comparative results of the EUS-FNA diagnosis and final diagnosis according to the location is showed in Table 2. Diagnostic yield of FNA was 85%. When the cases with an insufficient material were excluded, the concordance of EUS-FNA with the final diagnosis was 98.2%. The diagnostic accuracy of EUS-FNA was 78.5% (11/14) in esophageal lesions and 86.5% (45/52) in gastric lesions. When nine patients with insufficient material were excluded from the study, the EUS-FNA had a specificity of 100% (95% confidence interval [CI], 90.4 to 100), sensitivity of 96.4% (95% CI, 86.2 to 96.4), PPV of 100% (95% CI, 89.4 to 100), and NPV of 96.8% (95% CI, 87.5 to 96.8) to differentiate a malignant lesion from a benign lesion (Table 3).
Table 2

Comparison between the Results of Fine Needle Aspiration and Final Diagnoses

EUS, endoscopic ultrasonography; FNA, fine needle aspiration; GIST, gastrointestinal stromal tumor; hx, histiocytosis.

Table 3

Performance Characteristics of Endoscopic Ultrasonography-Guided Fine Needle Aspiration for Differentiating Benign from Malignant Subepithelial Tumors

EUS, endoscopic ultrasonography; FNA, fine needle aspiration; TN, true negative; FN, false negative; FP, false positive; TP, true positive.

a)One patient who had the diagnosis of leiomyoma by FNA, referred to operation due to the size of 40 mm and the presence of cystic structures. Final diagnosis was gastrointestinal stromal tumor.

In 27 patients the final diagnosis of GIST was obtained by cytological examination of the surgical material and all of these lesions were CD 117 (c-kit) positive. Cell blocks were obtained from only seven of these 27 patients (26%) by EUS-FNA and all of them were positive for c-kit. A patient with a lesion that was considered to be a leiomyoma due to the lack of c-kit positivity in cell block and another patient in whom the material obtained was insufficient were sent to surgery because of the suspicious characteristics of EUS findings. In these patients' lesions, postoperative c-kit was positive. Diagnostic accuracy of EUS combined with FNA for GIST was 92.5%. In the univariate analysis for inadequate material, the frequency of failing to obtain an adequate material was significantly higher in patients with a lesion size below 25 mm (p=0.04). However, multivariate analysis showed that the size of the lesion did not predict the adequacy of the material (p=0.8). In univariate analysis, other characteristics of the lesion (lesion echo pattern, origin of the lesion, location of the lesion) did not appear to have an effect on diagnostic yield of FNA.

DISCUSSION

EUS has an increasing role in the evaluation of subepithelial lesions. It enables endoscopists to differentiate an extramural lesion from an intramural one and shows the layer of origin. Besides, ultrasonographic appearance may also suggest a possible diagnosis. EUS-FNA is an invaluable adjunct in most of these instances. Forceps biopsies from the mucosal surface are usually nondiagnostic and more aggressive biopsy techniques using snares or puncture may be hazardous if the cause of bulging is not definitive. However, there are still some caveats about the accuracy of EUS and EUS-FNA in the diagnosis of subepithelial lesions. First, differentiation of the layer of origin is not perfect.4 Second, differentiation of a GIST from a leiomyoma is not always possible.5 Third, due to the firm nature of GISTs, cytologic yield may be poor and overly blood-stained material may be difficult to interpret.6 The specificity and sensitivity of EUS in subepithelial lesions were reported between 88% to 100% and 84% to 92%, respectively.7,8 In this study, the specificity and sensitivity of EUS-FNA to distinguish the malignant potential of subepithelial lesions were 100% and 96.4%, respectively. Our results are concordant with findings in the literature. Watson et al.9 reported that the diagnostic yield of EUS-FNA was 74% irrespective of the presence or absence of an onsite cytopathologist. In another study, the diagnostic yield of EUS-FNA was reported to be as 100% in the presence of an onsite cytopatologist.10 In our study, despite the absence of an onsite cytopathologist, the diagnostic yield of EUS-FNA was 85%. We found that lesion characteristics had no significant effect on the adequacy of FNA material in multivariate analyses. However, the adequacy of EUS-FNA obtained from a lesion larger than 25 mm was significantly better in univariate analyses. Mekky et al.8 have reported that the size and echo pattern of the lesion were significant factors in obtaining sufficient material through FNA in univariate analyses. However, the size has turned out to be statistically insignificant in multivariate analysis. Hoda et al.11 reported that there were no identifiable factors that affected the yield of EUS-FNA. GISTs are often discovered during routine endoscopy as a submucosal bulge or a raised lesion with an overlying normal mucosa. Endosonographically, GIST appears as hypoecoic round or oval mass, most often arising from the muscularis propria. In a prospective study of 23 patients with GISTs, EUS features alone had a diagnostic accuracy of 78%.12 EUS features alone are inadequate in distinguishing benign from malignant or potentially malignant stromal cell tumors.13 Thus, to fully characterize a subepithelial lesion and achieve a definite diagnosis, a tissue specimen is usually required. In previous studies, sensitivity and diagnostic accuracy of EUS completed with FNA in GISTs have been reported between 78% to 91%.11,12 This rate was 92.5% in our series. In seven GIST patients we obtained cell block (26%). It was reported that the rate of cell block obtainment in GIST patients was 25%.14 Undoubtfully with cell block examination the diagnostic accuracy of FNA will be increased but to have enough material from these firm tumors with FNA is difficult. The frequency of esophageal submucosal tumors is low. They are usually benign and asymptomatic. Wehrmann et al.15 reported the diagnostic accuracy rate of FNA for the esophageal submucosal lesions as 81.8%. The diagnostic yield of EUS-FNA in the esophageal lesions was reported as low as 43% by Watson et al.9 In our study, this was 78.5%. EUS-FNA can be performed much easier in the esophagus in contrast to other locations because of the straight position of the scope which results in easier advance of the needle within the lesion. However, the tangential position and respiratory oscillations can still influence the diagnostic yield. An incidentally detected subepithelial lesion could be due to compression of a mediastinal lesion. Recent studies have shown high accuracy rates of EUS in the diagnosis of a mediastinal adenopathy of unknown origin (94%).16 In our series, EUS-FNA was performed due to extrinsic pressure on esophagus in three patients. One patient was diagnosed with lung carcinoma and another with mediastinal metastasis of malign melanoma based on FNA. In the third patient FNA was nondiagnostic and the final diagnosis of Langerhans cell histiocytosis was obtained by mediastinoscopy. Another lesion which causes esophageal external compression is a duplication cyst. Although these cystic lesions are generally intramural and are found in the mid and lower parts of the esophagus, they may also have an extramural origin as this was the case in one of our patients. In conclusion, in case of necessity, EUS completed by FNA is an invaluable method in the diagnosis of subepithelial lesions. Taking into account the inevitable shortcomings of FNA, EUS features judged by an experienced endosonographer may be very important in some cases and, even in the absence of an on-site cytopathologist, the diagnostic yield can still be high.
  16 in total

1.  The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis.

Authors:  Nobuhiro Ando; Hidemi Goto; Yasumasa Niwa; Yoshiki Hirooka; Naoki Ohmiya; Tetsuo Nagasaka; Tetsuo Hayakawa
Journal:  Gastrointest Endosc       Date:  2002-01       Impact factor: 9.427

2.  Endosonographic diagnosis of submucosal upper gastrointestinal tract lesions and large fold gastropathies by catheter ultrasound probe.

Authors:  E Buscarini; M D Stasi; S Rossi; M Silva; F Giangregorio; Z Adriano; L Buscarini
Journal:  Gastrointest Endosc       Date:  1999-02       Impact factor: 9.427

3.  Diagnosis of submucosal tumor of the upper GI tract by endoscopic resection.

Authors:  T Kojima; H Takahashi; A Parra-Blanco; K Kohsen; R Fujita
Journal:  Gastrointest Endosc       Date:  1999-10       Impact factor: 9.427

4.  Yield and performance characteristics of endoscopic ultrasound-guided fine needle aspiration for diagnosing upper GI tract stromal tumors.

Authors:  Rabindra R Watson; Kenneth F Binmoeller; Chris M Hamerski; Amandeep K Shergill; Richard E Shaw; Ian M Jaffee; Lygia Stewart; Janak N Shah
Journal:  Dig Dis Sci       Date:  2011-03-01       Impact factor: 3.199

5.  Diagnostic utility of EUS-guided FNA in patients with gastric submucosal tumors.

Authors:  Mohamed A Mekky; Kenji Yamao; Akira Sawaki; Nobumasa Mizuno; Kazuo Hara; Mohamed A Nafeh; Ashraf M Osman; Takashi Koshikawa; Yasushi Yatabe; Vikram Bhatia
Journal:  Gastrointest Endosc       Date:  2010-03-11       Impact factor: 9.427

6.  Mediastinal lymphadenopathy in patients with or without previous malignancy: EUS-FNA-based differential cytodiagnosis in 153 patients.

Authors:  A Fritscher-Ravens; P V Sriram; C Bobrowski; A Pforte; T Topalidis; C Krause; S Jaeckle; F Thonke; N Soehendra
Journal:  Am J Gastroenterol       Date:  2000-09       Impact factor: 10.864

7.  EUS-guided sampling of suspected GI stromal tumors.

Authors:  Katherine M Hoda; Sarah A Rodriguez; Douglas O Faigel
Journal:  Gastrointest Endosc       Date:  2009-04-25       Impact factor: 9.427

8.  Endoscopic diagnosis of submucosal gastric lesions. The results after routine endoscopy.

Authors:  J L Hedenbro; M Ekelund; P Wetterberg
Journal:  Surg Endosc       Date:  1991       Impact factor: 4.584

9.  Combined endosonography and fine-needle aspiration cytology in the evaluation of gastrointestinal lesions.

Authors:  M J Wiersema; L M Wiersema; Q Khusro; H M Cramer; L C Tao
Journal:  Gastrointest Endosc       Date:  1994 Mar-Apr       Impact factor: 9.427

10.  Guillotine needle biopsy as a supplement to endosonography in the diagnosis of gastric submucosal tumors.

Authors:  G C Caletti; E Brocchi; A Ferrari; G Bonora; D Santini; G Mazzoleni; L Barbara
Journal:  Endoscopy       Date:  1991-09       Impact factor: 10.093

View more
  8 in total

1.  Extra-mucosal enucleation is still a safe and feasible treatment option of giant esophageal leiomyomas.

Authors:  Azhar Perwaiz; Vinay Kumar Shaw; Amanjeet Singh; Adarsh Chaudhary
Journal:  Indian J Gastroenterol       Date:  2018-02-21

2.  Natural History of Asymptomatic Esophageal Subepithelial Tumors of 30 mm or Less in Size.

Authors:  Seokin Kang; Do Hoon Kim; Yuri Kim; Dongsub Jeon; Hee Kyong Na; Jeong Hoon Lee; Ji Yong Ahn; Kee Wook Jung; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung
Journal:  J Korean Med Sci       Date:  2022-06-13       Impact factor: 5.354

3.  Use of Artificial Intelligence in the Prediction of Malignant Potential of Gastric Gastrointestinal Stromal Tumors.

Authors:  Gulseren Seven; Gokhan Silahtaroglu; Koray Kochan; Ali Tuzun Ince; Dilek Sema Arici; Hakan Senturk
Journal:  Dig Dis Sci       Date:  2021-02-06       Impact factor: 3.199

4.  Which needle is better for diagnosing subepithelial lesions?

Authors:  Eun Young Kim
Journal:  Clin Endosc       Date:  2015-03-27

5.  Differentiating Gastrointestinal Stromal Tumors from Leiomyomas Using a Neural Network Trained on Endoscopic Ultrasonography Images.

Authors:  Gulseren Seven; Gokhan Silahtaroglu; Ozden Ozluk Seven; Hakan Senturk
Journal:  Dig Dis       Date:  2021-10-07       Impact factor: 3.421

6.  Diagnosis of subepithelial lesion: still "tissue is the issue".

Authors:  Eun Young Kim
Journal:  Clin Endosc       Date:  2013-07-31

7.  The role of EUS and EUS-guided FNA in the management of subepithelial lesions of the esophagus: A large, single-center experience.

Authors:  Birol Baysal; Omar A Masri; Mohamad A Eloubeidi; Hakan Senturk
Journal:  Endosc Ultrasound       Date:  2017 Sep-Oct       Impact factor: 5.628

8.  The Role of Endoscopic Ultrasound in the Diagnostic Assessment of Subepithelial Lesions of the Upper Gastrointestinal Tract.

Authors:  Francisca Dias de Castro; Joana Magalhães; Sara Monteiro; Sílvia Leite; José Cotter
Journal:  GE Port J Gastroenterol       Date:  2016-07-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.